| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1998 | 2014 | |||||||||
|
RNA, U1 small nuclear 4 | 0.626 | 0.577 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1997 | 2014 | |||||||||
|
hepatocellular carcinoma associated transcript 5 | 0.716 | 0.462 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | |||||||||
|
microRNA 10a | 0.513 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2020 | |||||||||
|
microRNA 126 | 0.447 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | |||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2017 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
cystatin 12, pseudogene | 0.641 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
cytochrome P450 2D6 | 0.597 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
MAS related GPR family member X3 | 0.529 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MAS related GPR family member X4 | 0.531 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
MAS related GPR family member X1 | 0.531 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 | 0.678 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 143 | 0.462 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 22 | 0.496 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
microRNA 27b | 0.529 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 29a | 0.459 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |